An Observational Drug Utilization Study of SYCREST® (asenapine) in the United Kingdom (P08308)

First published 31/05/2017

Last updated 02/07/2024

EU PAS number:

EUPAS17681

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

8274-108+Protocol+AM3_final-redaction

English (304.77 KB - PDF)View document

Study results

Study results

MK-8274-108_final-report_NoAppendices_final-redaction

English (2.2 MB - PDF)View document

Study report

Other information